The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

0.94%Dividend Yield

Jun 26

$0.13

Dec 25

$0.16

Jun 25

$0.15

Dec 24

$0.11

Jun 24

$0.11

10Y Growth

N/A

5Y Growth

-1.86%

3Y Growth

5.38%

1Y Growth

-8.92%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IDNA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

ARK Genomic Revolution

ARKG

Mkt Cap0

ARK Genomic Revolution ETF focuses on companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, genomics, and molecular diagnostics, directly competing with IDNA's focus on genomics and healthcare.

Global X Genomics & Biotechnology

GNOM

Mkt Cap0

Global X Genomics & Biotechnology ETF invests in companies involved in genomics and biotechnology, directly aligning with IDNA's investment in genomics and healthcare sectors.

VanEck Biotech

BBH

Mkt Cap0

VanEck Vectors Biotech ETF provides exposure to companies in the biotech industry, which overlaps significantly with the genomics, immunology, and healthcare focus of IDNA.

First Trust NYSE Arca Biotechnology Index Fund

FBT

Mkt Cap0

First Trust NYSE Arca Biotechnology Index Fund tracks an index of biotechnology and pharmaceutical companies, competing with IDNA by investing in similar sectors of healthcare and biotech.

iShares Biotechnology

IBB

Mkt Cap0

iShares Biotechnology ETF offers exposure to U.S. biotechnology and pharmaceutical companies, directly competing with IDNA's focus on the healthcare and genomics sectors.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF provides exposure to the biotechnology sector, which includes companies involved in genomics and immunology, making it a direct competitor to IDNA.

Invesco Biotechnology & Genome

PBE

Mkt Cap0

Invesco Dynamic Biotechnology & Genome ETF invests in companies that are principally engaged in the research, development, manufacturing, and distribution of various biotechnological products, therapies, and services, including those in genomics, competing directly with IDNA.

Principal Healthcare Innovators

BTEC

Mkt Cap0

Principal Healthcare Innovators Index ETF focuses on small and mid-cap companies in the healthcare sector, including genomics and biotechnology, making it a competitor to IDNA.

ALPS Medical Breakthroughs

SBIO

Mkt Cap0

ALPS Medical Breakthroughs ETF targets companies with one or more drugs in Phase II or Phase III FDA clinical trials, which overlaps with IDNA's focus on innovative healthcare and genomics companies.

iShares Self-Driving EV and Tech

IDRV

Mkt Cap0

iShares Self-Driving EV and Tech ETF, while focused on electric vehicles and technology, indirectly competes with IDNA by investing in technology advancements, including those that could impact healthcare and genomics through innovation in related technologies.

Holdings

Regions

Sectors

About

The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.

CEO

Country

United States

ISIN

US46435U1925

Listings

0 Comments

Share your thoughts

FAQ

What is iShares Genomics Immunology and Healthcare stock price today?▼

The current price of IDNA is $29.96 USD — it has increased by +0.64% in the past 24 hours. Watch iShares Genomics Immunology and Healthcare stock price performance more closely on the chart.

What is iShares Genomics Immunology and Healthcare stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange iShares Genomics Immunology and Healthcare stocks are traded under the ticker IDNA.

Is iShares Genomics Immunology and Healthcare stock price growing?▼

IDNA stock has risen by +3.1% compared to the previous week, the month change is a +3.99% rise, over the last year iShares Genomics Immunology and Healthcare has showed a +41.59% increase.

Does iShares Genomics Immunology and Healthcare pay dividends?▼

Yes, IDNA dividends are paid semi-annual. The last dividend per share was 0.16 USD. As of today, Dividend Yield (FWD)% is 0.94%.

In which sector is iShares Genomics Immunology and Healthcare located?▼

iShares Genomics Immunology and Healthcare operates in the Other sector.

When did iShares Genomics Immunology and Healthcare complete a stock split?▼

iShares Genomics Immunology and Healthcare has not had any recent stock splits.